Meta-analysis of Fructose-Containing Sugar Sweetened Beverages (SSBs) and Weight Change
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Since uncontrolled observational studies first linked fructose to the epidemic of obesity almost a decade ago, it has become a focus of intense concern regarding its role in the obesity epidemic. Despite the uncertainties in the evidence,the recommendations of international health organizations have cautioned against moderate to high intakes fructose-containing sugars, especially those from sugar sweetened beverages (SSBs). To improve the evidence on which nutrition recommendations are based, the investigators propose to study of the effect of fructose-containing sugar sweetened beverages (SSBs)on body weight, by undertaking a systematic synthesis of the data taken from all available clinical studies in humans. This technique has the strength of allowing all of the available data to be pooled together and differences to be explored in groups of different study participants (healthy humans of different sex, weight, and age and in those with diseases which predispose to disturbances in metabolism, such as diabetes) with dietary fructose in different forms, doses, and with differing durations of exposure. The findings generated by this proposed knowledge synthesis will help improve the health of consumers through informing recommendations for the general public, as well as those at risk of diabetes and cardiovascular disease.
| Condition | Intervention |
|---|---|
|
Overweight Obesity Diabetes Prediabetes Dysglycemia Metabolic Syndrome |
Other: Fructose-containing sugar sweetened beverages |
| Study Type: | Observational |
| Study Design: | Time Perspective: Prospective |
| Official Title: | Effect of Fructose-containing Sugar Sweetened Beverages (SSBs) on Body Weight: A Systematic Review and Meta-analysis of Controlled Feeding Trials to Provide Evidence-based Guidance for Nutrition Guidelines Development |
- Body weight [ Time Frame: 1.5-years ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 1 |
| Study Start Date: | May 2012 |
| Estimated Study Completion Date: | December 2013 |
| Estimated Primary Completion Date: | May 2013 (Final data collection date for primary outcome measure) |
-
Other: Fructose-containing sugar sweetened beverages
Show Detailed Description
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Varied
Inclusion Criteria:
- Trials in humans
- Oral fructose intervention
- Suitable control (i.e. another carbohydrate source in isocaloric exchange for fructose or a control diet which is compared with the same diet supplemented with excess energy from fructose)
- >= 7-days diet duration
- Viable endpoint data
Exclusion Criteria:
- Non-human studies
- IV or parenteral fructose
- High fructose corn syrup or sucrose intervention (except where these are the comparators)
- Lack of a suitable control
- < 7-days diet duration.
- No viable endpoint data
Contacts and Locations| Canada, Ontario | |
| The Toronto 3D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Micheal's Hospital | |
| Toronto, Ontario, Canada, M5C 2T2 | |
| Study Director: | John L Sievenpiper, MD, PhD | Department of Pathology and Molecular Medicine, McMaster University and Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital |
| Study Director: | Russell J de Souza, ScD, RD | Department of Epidemiology and Biostatistics, McMaster University and Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital |
| Principal Investigator: | David JA Jenkins, MD, PhD, DSc | Department of Nutritional Sciences and Medicine, University of Toronto and Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital |
More Information
Publications:
| Responsible Party: | John Sievenpiper, Adjunct Research Fellow, University of Toronto |
| ClinicalTrials.gov Identifier: | NCT01608607 History of Changes |
| Other Study ID Numbers: | CCC 2012 KRS |
| Study First Received: | May 14, 2012 |
| Last Updated: | June 23, 2012 |
| Health Authority: | Canada: Ethics Review Committee |
Keywords provided by University of Toronto:
|
Systematic review and meta-analysis Evidence-based medicine (EBM) Evidence-based nutrition (EBN) Clinical practice guidelines Clinical trials Dietary sugars Fructose High fructose corn syrup |
sucrose Isocaloric Hypercaloric Glycemic control Insulin resistance Body weight body mass index waist circumference |
Additional relevant MeSH terms:
|
Obesity Glucose Intolerance Prediabetic State Overweight Metabolic Syndrome X Overnutrition Nutrition Disorders Body Weight |
Signs and Symptoms Hyperglycemia Glucose Metabolism Disorders Metabolic Diseases Diabetes Mellitus Endocrine System Diseases Insulin Resistance Hyperinsulinism |
ClinicalTrials.gov processed this record on June 13, 2013